Abbvie Inc (ABBV) Stock Price, Graph, News & Analysis
() | NEW YORK STOCK EXCHANGE INC. : ABBV
$159.62 -$7.67 (-4.58%)
Market Status : Closed
Last Update :
4/26/2024 4:00:02 PM
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) Read More
Historical Price Graph
Performance
| 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year |
|---|---|---|---|---|---|---|
| -5.38% | 2.25% | 17.35% | 10% | 5.57% | 15.7% | 164.58% |
Details
Exchange
NEW YORK STOCK EXCHANGE INC.
Industry
Website
https://www.abbvie.com/
Sector
CEO
Richard Gonzalez
Total Employees
50,000
SIC Code
2834
Market Cap
$ 282.63 B
Key Statistics
Dividend Rate
$5.98
Last Dividend
2024-04-12
Dividend Yield
3.57%
P/E Ratio
58.68
Price Range (52 Week)
$125.85 - $181.20
Latest Volume
$ 10.72 M
Average Total Volume
$ 5.28 M
Outstanding Shares
1,770,646,983
Beta
Similar Stocks
| Companyarrow_upward | Sectorarrow_upward | Latest Pricearrow_upward | Changearrow_upward |
|---|---|---|---|
| Coca-Cola Co (KO) | Consumer Non-Durables | $61.74 | $0.00 |
| Salesforce Inc (CRM) | Technology Services | $274.29 | $1.15 |
| Advanced Micro Devices Inc. (AMD) | Electronic Technology | $157.40 | $3.64 |
| Invesco Capital Management LLC - Invesco QQQ Trust Series 1 (QQQ) | Miscellaneous | $431.00 | $6.55 |
| Netflix Inc. (NFLX) | Consumer Services | $561.23 | -$3.57 |
Abbvie Inc in News
Benzinga (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
Ex-Humira Growth Platform Drives AbbVie''s Q1 Performance, Drugmaker Lifts Annual Profit Outlook Friday, AbbVie Inc (NYSE: ABBV ) reported first-quarter adjusted EPS of $2.31, down 6.1% Y/Y, beatin Apr 26, 2024 9:54 AM
Kwhen Finance (ABBV,FBIO)
Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer Apr 23, 2024 8:00 AM
InvestorPlace (JNJ,JNJ-GF,JNJ-GM,JNJ-GY,JNJ-GH,JNJ-GS,JNJ-GI,JNJ-GD,JNJ-GB,ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB,PPG,0KEI-LN,ADM,0JQQ-LN,ADM-GF,ADM-GM,ADM-GY,ADM-GH,ADM-GS,ADM-GI,ADM-GD,ADM-GB,ABT,ABL-GF,ABL-GM,ABL-GY,ABL-GH,ABL-GS,ABL-GI,ABL-GD,ABL-GB,ABT-SE,SSTK,0A8F-LN,KVUE)
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip Dividend stocks have a proven record of stock market outperformance. For nearly 100 years, income-ge Apr 22, 2024 8:00 AM
InvestorPlace (JNJ,JNJ-GF,JNJ-GM,JNJ-GY,JNJ-GH,JNJ-GS,JNJ-GI,JNJ-GD,JNJ-GB,ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB,NVDA,NVD-GF,NVD-GM,NVD-GY,NVD-GH,NVD-GS,NVD-GI,NVD-GD,NVD-GB,NVDA-QH,CRBP,CRBP,0SZI-LN,SMCI,BMY,CELG^,BRM-GF,BRM-GM,BRM-GY,BRM-GH,BRM-GS,BRM-GI,BRM-GD,BRM-GB,DAVEW,DAVE,DAVE)
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher? Small-cap stocks tend to outperform their larger brethren over time. After several years of underper Apr 19, 2024 2:30 PM
Seeking Alpha (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
AbbVie Q1 Earnings Preview: No Repeat Of Last Year''s Q1 Disappointment AbbVie soon releases Q1 2024 earnings and faces losing patent protection for its best-selling drug, Apr 18, 2024 1:46 PM
Seeking Alpha (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
AbbVie succeeds in late-stage trial for Rinvoq in inflammatory condition No summary available. Apr 18, 2024 9:30 AM
Seeking Alpha (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB,EVR,QGJ-GF,QGJ-GM,QGJ-GS,QGJ-GD,0HRS-LN,CVS-GF,CVS-GM,CVS-GY,CVS-GS,CVS-GD,CVS-GB)
CVS favors Humira copycats hurting AbbVie’s market share: Evercore No summary available. Apr 17, 2024 9:26 AM
TipRanks (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
AbbVie Stock (NYSE:ABBV): Humira Leads Market with 96% Share Pharmaceutical company AbbVie’s (NYSE:ABBV) arthritis drug, Humira, continues to dominate the market Apr 15, 2024 2:30 AM
Seeking Alpha (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
AbbVie: Still Fits Buffett''s 10x EBT Rule Well Despite Guidance Revision AbbVie''s stock price fell by about 7% last week after the company revised its full-year and Q1 guid Apr 8, 2024 11:25 AM
Benzinga (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
AbbVie Unusual Options Activity For April 05 Whales with a lot of money to spend have taken a noticeably bearish stance on AbbVie . Looking at op Apr 5, 2024 4:15 PM
Common Questions Related to Abbvie Inc
What is dividend yield of Abbvie Inc stock?
Abbvie Inc dividend yield is 0.0357231311161938 and Abbvie Inc announced last dividend in 2024-04-12 of amount $5.98/stock.
What is Abbvie Inc stock symbol?
Abbvie Inc traded in NEW YORK STOCK EXCHANGE INC. stock exchange and the stock symbol/ticker is ABBV
What is the latest share price of Abbvie Inc (ABBV)? or What is Abbvie Inc stock price today?
Abbvie Inc latest stock price is $159.62
Where is Abbvie Inc headquarter?
Abbvie Inc headquarter is at – 1 N Waukegan Rd, North Chicago, Illinois, US
What is the total market cap of Abbvie Inc company?
The total market value of Abbvie Inc stock is $ 296.21 B
What is the P/E ratio of Abbvie Inc stock?
Abbvie Inc P/E ratio is 61.45467505935062
What is the EPS of Abbvie Inc stock?
Abbvie Inc EPS is 2.72
Related Tags
Abbvie Inc stock price history, Abbvie Inc stock quote, ABBV current stock price, Abbvie Inc dividend yield, Abbvie Inc Dividend, How much is Abbvie Inc worth